title: Germline mutations of the MEN1 gene in Korean families with multiple endocrine neoplasia type 1 (MEN1) or MEN1-related disorders.
abstract: Multiple endocrine neoplasia type 1 (MEN1) is a familial cancer syndrome characterized by the combined occurrence of tumours of the parathyroid glands, pancreatic islet cells and anterior pituitary gland. Mutation analysis of the MEN1 gene has enabled the genetic diagnosis of patients with MEN1. Two MEN1-related disorders - familial isolated hyperparathyroidism (FIHP) and familial pituitary adenoma - are considered to be variants of MEN1, or at least to be incompletely expressed variants. Germline mutations of the MEN1 gene have been reported in some with FIHP, but familial pituitary adenoma usually lacks the MEN1 mutation and has been described as a genetically distinct disorder. In this work, we investigated five Korean families with MEN1, one family with FIHP and one family with familial pituitary adenoma. Polymerase chain reaction (PCR)-based single-strand conformation polymorphism (PCR-SSCP) analysis, denaturing high-performance liquid chromatography (DHPLC) and sequencing were used to detect the MEN1 mutations. Screening of the genetic variations of the MEN1 gene revealed four germline mutations in five typical MEN1 families. All four germline mutations led to truncated proteins or a change in the amino acids of the functional domains. In this study, we identified three novel MEN1 germline mutations (969C >A, 973G >C and 1213C >T) and one previously reported mutation (200-201insAGCCC). The frequency of the MEN1 germline mutation in Korean MEN1 families (four of five; 80%) was similar to those reported previously. In accordance with previous studies, no MEN1 germline mutation was detected in two families with FIHP or familial pituitary adenoma.
authors.affiliation: Korean Hereditary Tumor Registry, Laboratory of Cell Biology, Cancer Research Center and Cancer Research Institute, Seoul National University, Seoul, Korea.
authors.forename: J-H
authors.initials: JH
authors.lastname: Park
authors.forename: I-J
authors.initials: IJ
authors.lastname: Kim
authors.forename: H C
authors.initials: HC
authors.lastname: Kang
authors.forename: S-H
authors.initials: SH
authors.lastname: Lee
authors.forename: Y
authors.initials: Y
authors.lastname: Shin
authors.forename: K-H
authors.initials: KH
authors.lastname: Kim
authors.forename: S-B
authors.initials: SB
authors.lastname: Lim
authors.forename: S-B
authors.initials: SB
authors.lastname: Kang
authors.forename: Ku
authors.initials: K
authors.lastname: Lee
authors.forename: S Y
authors.initials: SY
authors.lastname: Kim
authors.forename: M-S
authors.initials: MS
authors.lastname: Lee
authors.forename: M-K
authors.initials: MK
authors.lastname: Lee
authors.forename: J-H
authors.initials: JH
authors.lastname: Park
authors.forename: S-D
authors.initials: SD
authors.lastname: Moon
authors.forename: J-G
authors.initials: JG
authors.lastname: Park
mesh_terms: D004252:DNA Mutational Analysis; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism / Q000235:genetics; D007723:Korea; D008297:Male; D018761:Multiple Endocrine Neoplasia Type 1 / Q000235:genetics*; D009154:Mutation; D010375:Pedigree; D015175:Prolactinoma / Q000235:genetics; D011518:Proto-Oncogene Proteins / Q000235:genetics*
chemical_list: C105373:MEN1 protein, human; D011518:Proto-Oncogene Proteins